Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05507814 · ClinicalTrials.gov registry record · NA
Temporal Window and Episodic Future Thinking in CUD
A NA study of Cocaine Use Disorder, sponsored by Virginia Polytechnic Institute and State University.
- Completed
- Registry status
- NA
- Development phase
- 141
- Enrollment target
- 1
- Study location
NCT05507814: Completed NA study of Cocaine Use Disorder, sponsored by Virginia Polytechnic Institute and State University.
NCT05507814 is a NA study of Cocaine Use Disorder that has completed, run by Virginia Polytechnic Institute and State University. The registered enrollment target is 141 participants, above the 98-participant average among 26 other Cocaine Use Disorder trials with a reported enrollment target (44% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05507814, a NA study of Cocaine Use Disorder, has completed, sponsored by Virginia Polytechnic Institute and State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 141 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective is to test the theory of Reinforcer Pathology via manipulation of the temporal window with successive Episodic Future Thinking generation in individuals with cocaine use disorder.
Primary Outcome
Delay discounting tasks provide a measure of the temporal window and examine the devaluation of awards as a function of the delay to the receipt. These computerized assessments provide participants with hypothetical choices between smaller amounts of a reward available immediately and a larger amount of a reward after a range of delays (1 day-25 years). Discounting rates will be measured using adjusting amount delay discounting and minute delay discounting tasks. Change in discounting rates will
Conditions Studied
Interventions
- BEHAVIORAL Episodic Future Thinking (EFT)
- BEHAVIORAL Control Episodic Thinking
Study Locations (1)
Virginia
- Fralin Biomedical Research Institute at VTC - Roanoke
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 141 participants |
| Start Date | 2022-11-30 |
| Est. Completion | 2025-11-24 |
| Phase | NA |
What the finished NCT05507814 record still lists
NCT05507814 is an interventional study that assigns participants to a tested intervention. The registered 141 participants enrollment target is mid-sized for trials with a published cap, above the 98-participant average among 26 other Cocaine Use Disorder trials with a reported enrollment target (44% higher).
The record links to 1 condition, with Cocaine Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which Episodic Future Thinking (EFT) is the first listed.
NCT05507814 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT05507814 about?
NCT05507814 is a clinical study titled "Temporal Window and Episodic Future Thinking in CUD". The primary objective is to test the theory of Reinforcer Pathology via manipulation of the temporal window with successive Episodic Future Thinking generation in individuals with cocaine use disorder.
What is the current status of trial NCT05507814?
This trial is currently completed. It is a NA study. The enrollment target is 141 participants. The study started on 2022-11-30. Estimated completion is 2025-11-24.
What conditions does trial NCT05507814 study?
This clinical trial studies the following conditions: Cocaine Use Disorder.
What interventions are being tested in trial NCT05507814?
The interventions under investigation include: Episodic Future Thinking (EFT) (BEHAVIORAL), Control Episodic Thinking (BEHAVIORAL).
Who is sponsoring clinical trial NCT05507814?
This trial is sponsored by Virginia Polytechnic Institute and State University, which has 104 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05507814 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cocaine Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05507814's enrollment target sits among peer trials
141 6th of 26 higher than 21 of 26 other Cocaine Use Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cocaine Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Encouraging Abstinence Behavior in a Drug Epidemic: Optimizing Dynamic Incentives
RECRUITING · NA
-
Cocaine Cue-reactivity Incubation Study
RECRUITING · NA
-
Identifying Electrophysiological Targets for Transcranial Magnetic Stimulation in Cocaine Use Disorder
RECRUITING · NA
-
Transcranial Direct Current Stimulation (tDCS) for Treatment of Cocaine Use Disorder
RECRUITING · NA
-
Contingency Management for Drug Use: Does Age Matter?
ACTIVE NOT RECRUITING · NA
-
Neurobehavioral Measurement of Substance Users in Outpatient Treatment Setting
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03042962 · 141 participants
Brain Networks in Dystonia
- NCT04378439 · 141 participants · NA
Appalachian Partnership to Reduce Disparities (Aim 2)
- NCT04775485 · 141 participants · Phase 2
A Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With Relapsed or Progressive Low-Grade Glioma and Advance Solid Tumors
- NCT05040360 · 141 participants · Phase 2
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI